1.
Theodosakis N. Inhibition of isoprenoid synthesis synergizes with MAPK blockade to prevent growth in targeted therapy-resistant melanoma. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 3];2:S114-S115. Available from: https://jofskin.org/33014/index.php/skin/article/view/453